(PGNX:Consolidated Issue Listed on NASDAQ Global Select )
Mark R. Baker J.D.
Chief Executive Officer, Director and Member of Science & Strategy Committee, Progenics Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 25 board members in 3 different organizations across 2 different industries.|
See Board Relationships
As of Fiscal Year 2013
Mr. Mark R. Baker, J.D. has been the Chief Executive Officer of Progenics Pharmaceuticals, Inc. since March 2011 and served as its President from September 2009 to March 3, 2011. Mr. Baker served as a Secretary and General Counsel of Progenics Pharmaceuticals, Inc. since June 20, 2005 and served as its Executive Vice President-Corporate from 2008 to 2009. He served as Senior Vice President of Progenics Pharmaceuticals Inc., since June 20, 2005. He served as Chief Legal ...
777 Old Saw Mill River RoadPhone: 914-789-2800
Tarrytown, New York 10591
Board Members Memberships*
Chairman of the Board, Member of Executive Committee and Member of Compensation Committee
Non-Executive Chairman of the Board, Chief Legal Officer of Contigroup and Senior Vice President of Contigroup
Chief Executive Officer, Director and Member of Science & Strategy Committee
School Of Law, Columbia University
Columbia Business School
|Ron Squarer BSc (Biochemistry), MBA||Chief Executive Officer and Director|
Array BioPharma, Inc.
|James A. Bianco M.D.||Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee|
CTI BioPharma Corp.
|J. Joseph Kim Ph.D.||Chief Executive Officer, President, Director and Member of Finance Committee|
Inovio Pharmaceuticals, Inc.
|Eddie Gray||Chief Executive Officer and Director|
Dynavax Technologies Corporation
|Jonathan J. Lewis M.D., Ph.D.||Chief Executive Officer and Director|
ZIOPHARM Oncology, Inc.
|$600.0K||Compensation as of Fiscal Year 2014.|